PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente (Andrea Park/FierceBiotech)

Andrea Park / FierceBiotech:
PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente  —  If its hundreds of millions in venture funding and wide-ranging cadre of big-named partners are any indication, PathAI's (ahem) path forward appears to be paved in gold.